{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:44:11Z","timestamp":1761662651876,"version":"3.35.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Parasitology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vetpar.2008.09.009","type":"journal-article","created":{"date-parts":[[2008,9,8]],"date-time":"2008-09-08T08:08:56Z","timestamp":1220861336000},"page":"215-222","source":"Crossref","is-referenced-by-count":45,"title":["Canine ABCB1 and macrocyclic lactones: Heartworm prevention and pharmacogenetics"],"prefix":"10.1016","volume":"158","author":[{"given":"Katrina L.","family":"Mealey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetpar.2008.09.009_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/vr.154.6.180","article-title":"Effect of grapefruit juice on the pharmacokinetics of cyclosporine in dogs","volume":"154","author":"Amatori","year":"2004","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetpar.2008.09.009_bib2","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1021\/jf061633l","article-title":"Prolonged persistence of fecally excreted ivermectin from reindeer in a sub-arctic environment","volume":"54","author":"Asbakk","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.vetpar.2008.09.009_bib3","unstructured":"Beagle Health Information, Canine: Heartworms and Inexpensive Prevention. Available at http:\/\/www.beaglesunlimited.com\/beaglehealth_canineheartworms.htm. Accessed November 29, 2007."},{"key":"10.1016\/j.vetpar.2008.09.009_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1472-8206.1999.tb00009.x","article-title":"The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac","volume":"13","author":"Bou\u00ebr","year":"1999","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1346476","article-title":"Modulation of activity of the promoter of the human MDR1 gene by Ras and p53","volume":"255","author":"Chin","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vetpar.2008.09.009_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0090-9556(24)15144-6","article-title":"Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes","volume":"28","author":"Choo","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.vetpar.2008.09.009_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood\u2013brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4615-3872-1_3","article-title":"Molecular biology of P-glycoprotein","volume":"57","author":"Cornwell","year":"1991","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0928-0987(00)00149-4","article-title":"In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin","volume":"12","author":"de Lange","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.vetpar.2008.09.009_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood\u2013brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetpar.2008.09.009_bib11","first-page":"1","article-title":"Endectocide use in cattle and fecal residues: environmental effects in Canada","volume":"70","author":"Floate","year":"2006","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00744664","article-title":"Pharmacologic circumvention of multidrug resistance","volume":"12","author":"Ford","year":"1993","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vetpar.2008.09.009_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2885.2005.00655.x","article-title":"Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein","volume":"28","author":"Griffin","year":"2005","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib14","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0022-3565(25)39349-3","article-title":"Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney","volume":"266","author":"Hori","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.vetpar.2008.09.009_bib16","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1096\/fasebj.3.14.2574119","article-title":"P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins","volume":"3","author":"Juranka","year":"1989","journal-title":"FASEB J."},{"key":"10.1016\/j.vetpar.2008.09.009_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI1269","article-title":"The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors","volume":"101","author":"Kim","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetpar.2008.09.009_bib18","first-page":"2827","article-title":"Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats","volume":"20","author":"Kiso","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15216540212646","article-title":"Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein","volume":"53","author":"Konings","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.vetpar.2008.09.009_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-9556(24)15253-1","article-title":"Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein","volume":"27","author":"Kwei","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.vetpar.2008.09.009_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6690475","article-title":"Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium","volume":"80","author":"Li","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.vetpar.2008.09.009_bib23","first-page":"20","article-title":"Non-P-glycoprotein drug export mechanisms of multidrug resistance","volume":"34","author":"List","year":"1997","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","article-title":"Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine","volume":"62","author":"Lown","year":"1997","journal-title":"Clin. Pharmacol Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":"Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1476-5829.2003.00015.x","article-title":"Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats","volume":"2","author":"McEntee","year":"2003","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.vetpar.2008.09.009_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vetpar.2005.05.004","article-title":"Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia","volume":"131","author":"Mealey","year":"2005","journal-title":"Vet Parasitol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib29","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1095\/biolreprod.102.003558","article-title":"Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, guinea pig, and human","volume":"67","author":"Melaine","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.vetpar.2008.09.009_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1365-2141.1999.01172.x","article-title":"P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications","volume":"104","author":"Michieli","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib31","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1073\/pnas.0402374101","article-title":"Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage","volume":"101","author":"Neff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib32","first-page":"3533","article-title":"Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines","volume":"20","author":"Page","year":"1987","journal-title":"Anticancer Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib33","first-page":"684","article-title":"Clinical observations in collies given ivermectin orally","volume":"48","author":"Paul","year":"1987","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib34","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1002\/1097-0142(19931215)72:12<3553::AID-CNCR2820721203>3.0.CO;2-B","article-title":"Clinical trials of agents that reverse multidrug resistance. A literature review","volume":"72","author":"Raderer","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.vetpar.2008.09.009_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkf049","article-title":"Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms","volume":"49","author":"Ramage","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.vetpar.2008.09.009_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1385\/JMN:20:3:339","article-title":"Overcoming the blood\u2013brain barrier to taxane delivery for neurodegenerative diseases and brain tumors","volume":"20","author":"Rice","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.vetpar.2008.09.009_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-2952(92)90666-7","article-title":"The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo","volume":"43","author":"Roninson","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mcp.2000.109156","article-title":"Increased drug delivery to the brain by P-glycoprotein inhibition","volume":"68","author":"Sadeque","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs","volume":"7","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.vetpar.2008.09.009_bib40","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vetpar.2008.09.009_bib41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0959-8049(95)00130-B","article-title":"Multidrug resistance and the role of P-glycoprotein knockout mice","volume":"31A","author":"Schinkel","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.vetpar.2008.09.009_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0009-9236(99)70107-4","article-title":"Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans","volume":"65","author":"Schwarz","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1432-1327.1998.2510252.x","article-title":"A general pattern for substrate recognition by P-glycoprotein","volume":"251","author":"Seelig","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vetpar.2008.09.009_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1525-5050(02)00511-5","article-title":"P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice","volume":"3","author":"Sills","year":"2002","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.vetpar.2008.09.009_bib45","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","article-title":"Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine","volume":"94","author":"Sparreboom","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib46","first-page":"545","article-title":"Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues","volume":"40","author":"Sugawara","year":"1990","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.vetpar.2008.09.009_bib47","first-page":"RA5","article-title":"Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction","volume":"10","author":"Sun","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.vetpar.2008.09.009_bib48","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10646-006-0085-1","article-title":"Abamectin in the aquatic environment","volume":"15","author":"Tisler","year":"2006","journal-title":"Ecotoxicology"},{"key":"10.1016\/j.vetpar.2008.09.009_bib50","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2460\/ajvr.1991.52.07.1170","article-title":"Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies","volume":"52","author":"Tranquilli","year":"1991","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetpar.2008.09.009_bib51","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1073\/pnas.84.9.3004","article-title":"Expression of a full-length cDNA for the human \u201cMDR1\u201d gene confers resistance to colchicine, doxorubicin, and vinblastine","volume":"84","author":"Ueda","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0893-133X(99)00095-0","article-title":"Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood\u2013brain barrier deficiency due to mdr1a P-glycoprotein gene disruption","volume":"22","author":"Uhr","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.vetpar.2008.09.009_bib53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2826.2002.00836.x","article-title":"Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins","volume":"14","author":"Uhr","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0005-2728(98)00039-5","article-title":"The ABC family of multidrug transporters in microorganisms","volume":"1365","author":"van Veen","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.vetpar.2008.09.009_bib55","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1073\/pnas.92.19.8921","article-title":"Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum","volume":"92","author":"Volkman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vetpar.2008.09.009_bib56","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.vetpar.2008.09.009_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0968-0004(90)90171-7","article-title":"What determines the substrate specificity of the multi-drug-resistance pump?","volume":"15","author":"West","year":"1990","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.vetpar.2008.09.009_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1067\/mcp.2000.107579","article-title":"Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein","volume":"68","author":"Westphal","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.vetpar.2008.09.009_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0166-6851(97)00215-6","article-title":"Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog","volume":"91","author":"Xu","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vetpar.2008.09.009_bib60","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/jpet.300.3.1063","article-title":"Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo","volume":"300","author":"Yamaguchi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Veterinary Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401708004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304401708004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T21:32:33Z","timestamp":1738359153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304401708004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0304401708004512"],"URL":"https:\/\/doi.org\/10.1016\/j.vetpar.2008.09.009","relation":{},"ISSN":["0304-4017"],"issn-type":[{"type":"print","value":"0304-4017"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}